Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277

1.

Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients.

Barta AL, Nutescu EA, Thompson PA, Bussey HI, Gulseth MP.

Am J Health Syst Pharm. 2015 Jul 15;72(14):1188-94. doi: 10.2146/ajhp140752.

PMID:
26150568
2.

Impact of a new method of warfarin management on patient satisfaction, time, and cost.

Meyer S, Frei CR, Daniels KR, Forcade NA, Bussey M, Bussey-Smith KL, Bussey HI.

Pharmacotherapy. 2013 Nov;33(11):1147-55. doi: 10.1002/phar.1344. Epub 2013 Aug 22.

PMID:
24038425
3.

Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.

Bussey HI, Bussey M, Bussey-Smith KL, Frei CR.

Pharmacotherapy. 2013 Nov;33(11):1136-46. doi: 10.1002/phar.1343. Epub 2013 Aug 22.

PMID:
24038412
4.

Larval ethanol exposure alters free-running circadian rhythm and per Locus transcription in adult D. melanogaster period mutants.

Ahmad ST, Steinmetz SB, Bussey HM, Possidente B, Seggio JA.

Behav Brain Res. 2013 Mar 15;241:50-5. doi: 10.1016/j.bbr.2012.11.035. Epub 2012 Dec 5.

5.

Cardiology patient page. Warfarin management: international normalized ratio self-testing and warfarin self-dosing.

Bussey HI, Bussey M.

Circulation. 2012 Jul 31;126(5):e52-4. doi: 10.1161/CIRCULATIONAHA.112.095877. No abstract available.

PMID:
22850365
6.

The future landscape of anticoagulation management.

Bussey HI.

Pharmacotherapy. 2011 Dec;31(12):1151-5. doi: 10.1592/phco.31.12.1151. No abstract available.

PMID:
22122177
7.

PA residues in the 2009 H1N1 pandemic influenza virus enhance avian influenza virus polymerase activity in mammalian cells.

Bussey KA, Desmet EA, Mattiacio JL, Hamilton A, Bradel-Tretheway B, Bussey HE, Kim B, Dewhurst S, Takimoto T.

J Virol. 2011 Jul;85(14):7020-8. doi: 10.1128/JVI.00522-11. Epub 2011 May 11.

8.

Transforming oral anticoagulation by combining international normalized ratio (INR) self testing and online automated management.

Bussey HI.

J Thromb Thrombolysis. 2011 Apr;31(3):265-74. doi: 10.1007/s11239-011-0564-y. Review.

PMID:
21327509
9.

A consensus conference on complex biologics and low molecular weight heparins.

Kalodiki E, Fareed J, Tapson VF, Hoppensteadt DA, Sussman I, Carter CA, Parker S, Harenberg J, Hull R, Rao G, Lovinger DF, Ried LD, Kakkar A, Talarico L, Ofuso F, Bussey HI, Fanikos J, Groce JB, Skinner N, Ahluwalia M, Iqbal O, Jackson CM, Jeske WP, Georges M, Ramacciotti E, Tapson VF, Van Thiel D, Wahi R, Walenga J.

Int Angiol. 2010 Apr;29(2):193-6. No abstract available.

PMID:
20351676
10.

Thrombotic risk and immobility in residents of long-term care facilities.

Zarowitz BJ, Tangalos E, Lefkovitz A, Bussey H, Deitelzweig S, Nutescu E, O'Shea T, Resnick B, Wheeler A.

J Am Med Dir Assoc. 2010 Mar;11(3):211-21. doi: 10.1016/j.jamda.2009.11.006. Epub 2010 Feb 4.

PMID:
20188319
11.

The net clinical benefit of warfarin anticoagulation in atrial fibrillation.

Bussey H.

Ann Intern Med. 2010 Feb 16;152(4):264-5; author reply 265. doi: 10.7326/0003-4819-152-4-201002160-00016. No abstract available.

PMID:
20157144
12.

The genetic landscape of a cell.

Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, Ding H, Koh JL, Toufighi K, Mostafavi S, Prinz J, St Onge RP, VanderSluis B, Makhnevych T, Vizeacoumar FJ, Alizadeh S, Bahr S, Brost RL, Chen Y, Cokol M, Deshpande R, Li Z, Lin ZY, Liang W, Marback M, Paw J, San Luis BJ, Shuteriqi E, Tong AH, van Dyk N, Wallace IM, Whitney JA, Weirauch MT, Zhong G, Zhu H, Houry WA, Brudno M, Ragibizadeh S, Papp B, Pál C, Roth FP, Giaever G, Nislow C, Troyanskaya OG, Bussey H, Bader GD, Gingras AC, Morris QD, Kim PM, Kaiser CA, Myers CL, Andrews BJ, Boone C.

Science. 2010 Jan 22;327(5964):425-31. doi: 10.1126/science.1180823.

13.

The financial viability of an anticoagulation clinic: a discussion from the anticoagulation forum meeting, May, 2009.

Bussey HI.

J Thromb Thrombolysis. 2010 Feb;29(2):227-32. doi: 10.1007/s11239-009-0417-0. No abstract available.

PMID:
19915803
14.

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.

Garcia D, Ageno W, Bussey H, Eikelboom J, Margaglione M, Marongiu F, Moia M, Palareti G, Pengo V, Poli D, Schulman S, Witt D, Wittkowksy A, Crowther M.

Am J Hematol. 2009 Sep;84(9):579-83. doi: 10.1002/ajh.21470. Review. No abstract available.

15.

Genetic interaction network of the Saccharomyces cerevisiae type 1 phosphatase Glc7.

Logan MR, Nguyen T, Szapiel N, Knockleby J, Por H, Zadworny M, Neszt M, Harrison P, Bussey H, Mandato CA, Vogel J, Lesage G.

BMC Genomics. 2008 Jul 15;9:336. doi: 10.1186/1471-2164-9-336.

16.

An in vivo map of the yeast protein interactome.

Tarassov K, Messier V, Landry CR, Radinovic S, Serna Molina MM, Shames I, Malitskaya Y, Vogel J, Bussey H, Michnick SW.

Science. 2008 Jun 13;320(5882):1465-70. doi: 10.1126/science.1153878. Epub 2008 May 8.

17.

Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus.

Fedorova ND, Khaldi N, Joardar VS, Maiti R, Amedeo P, Anderson MJ, Crabtree J, Silva JC, Badger JH, Albarraq A, Angiuoli S, Bussey H, Bowyer P, Cotty PJ, Dyer PS, Egan A, Galens K, Fraser-Liggett CM, Haas BJ, Inman JM, Kent R, Lemieux S, Malavazi I, Orvis J, Roemer T, Ronning CM, Sundaram JP, Sutton G, Turner G, Venter JC, White OR, Whitty BR, Youngman P, Wolfe KH, Goldman GH, Wortman JR, Jiang B, Denning DW, Nierman WC.

PLoS Genet. 2008 Apr 11;4(4):e1000046. doi: 10.1371/journal.pgen.1000046.

18.

Genetic testing for warfarin dosing? Not yet ready for prime time.

Bussey HI, Wittkowsky AK, Hylek EM, Walker MB.

Pharmacotherapy. 2008 Feb;28(2):141-3. doi: 10.1592/phco.28.2.141. No abstract available.

PMID:
18225960
19.

Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans.

Xu D, Jiang B, Ketela T, Lemieux S, Veillette K, Martel N, Davison J, Sillaots S, Trosok S, Bachewich C, Bussey H, Youngman P, Roemer T.

PLoS Pathog. 2007 Jun;3(6):e92.

20.

The localization of nuclear exporters of the importin-beta family is regulated by Snf1 kinase, nutrient supply and stress.

Quan X, Yu J, Bussey H, Stochaj U.

Biochim Biophys Acta. 2007 Jul;1773(7):1052-61. Epub 2007 May 1.

21.

Exploring genetic interactions and networks with yeast.

Boone C, Bussey H, Andrews BJ.

Nat Rev Genet. 2007 Jun;8(6):437-49. Review.

PMID:
17510664
22.

Dietary supplement use among anticoagulation clinic patients.

Wittkowsky AK, Bussey HI, Walker MB, Frei CR.

J Thromb Haemost. 2007 Apr;5(4):875-7. Epub 2007 Jan 9. No abstract available.

23.

Retrievable and permanent inferior vena cava filters: selected considerations.

Anderson RC, Bussey HI.

Pharmacotherapy. 2006 Nov;26(11):1595-600. Review.

PMID:
17064204
24.

From worm genetic networks to complex human diseases.

Bussey H, Andrews B, Boone C.

Nat Genet. 2006 Aug;38(8):862-3. No abstract available.

PMID:
16874324
25.

Cell wall assembly in Saccharomyces cerevisiae.

Lesage G, Bussey H.

Microbiol Mol Biol Rev. 2006 Jun;70(2):317-43. Review.

26.

A screen for genes of heme uptake identifies the FLC family required for import of FAD into the endoplasmic reticulum.

Protchenko O, Rodriguez-Suarez R, Androphy R, Bussey H, Philpott CC.

J Biol Chem. 2006 Jul 28;281(30):21445-57. Epub 2006 May 22.

27.

Low-dose vitamin K to augment anticoagulation control.

Reese AM, Farnett LE, Lyons RM, Patel B, Morgan L, Bussey HI.

Pharmacotherapy. 2005 Dec;25(12):1746-51.

PMID:
16305294
28.

Duration of treatment of deep vein thrombosis: time for a new approach?

Rychlik PG, Henry KS, Bussey HI.

Pharmacotherapy. 2005 Aug;25(8):1112-5. Review.

PMID:
16207102
29.

Opinions and research priorities.

Bussey HI, Tapson V, Cannon RO 3rd, Nolan PE Jr, Gage B, Penzak SR, Spinler SA, De Smet P, Wittkowsky A, Lee AP, Ernst E, Marder VJ.

Thromb Res. 2005;117(1-2):155-69; discussion 170-4. Epub 2005 Aug 15. No abstract available.

PMID:
16099491
30.

Motifs, themes and thematic maps of an integrated Saccharomyces cerevisiae interaction network.

Zhang LV, King OD, Wong SL, Goldberg DS, Tong AH, Lesage G, Andrews B, Bussey H, Boone C, Roth FP.

J Biol. 2005;4(2):6. Epub 2005 Jun 1.

31.

Problems with co-funding in Canada.

Tyers M, Brown E, Andrews DW, Bergeron JJ, Boone C, Bremner R, Bussey HA, Cross JC, Davies JE, Desjardins M, Dick JE, Dumont DJ, Durocher D, Ellison MJ, Golding GB, Gray MW, Harrington LA, Hieter PA, Johnston G, Kelvin DJ, McCarry BE, Michnick SW, Ouellette F, Pearlman RE, Penn LJ, Pelletier J, Rachubinski RA, Rennie PS, Rotin D, Rottapel R, Sadowski I, Sicheri F, Siminovitch L, Sonenberg N, Siu KW, Tremblay ML, Winegarden N, Wozniak RW, Wright GD, Woodgett JR.

Science. 2005 Jun 24;308(5730):1867. No abstract available.

PMID:
15976286
32.

An interactional network of genes involved in chitin synthesis in Saccharomyces cerevisiae.

Lesage G, Shapiro J, Specht CA, Sdicu AM, Ménard P, Hussein S, Tong AH, Boone C, Bussey H.

BMC Genet. 2005 Feb 16;6:8.

33.

Oral anticoagulation: challenges in the case-management setting.

Lowery S, Haley K, Bussey HI.

Lippincotts Case Manag. 2005 Jan-Feb;10(1):39-50. Review.

PMID:
15685010
34.

Transitioning from traditional to novel anticoagulants: the impact of oral direct thrombin inhibitors on anticoagulation management.

Nutescu EA, Spinler SA, Dager WE, Bussey HI.

Pharmacotherapy. 2004 Oct;24(10 Pt 2):199S-202S.

PMID:
15624340
35.

The role of oral direct thrombin inhibitors in the treatment of venous thromboembolism.

Busti AJ, Bussey HI.

Pharmacotherapy. 2004 Oct;24(10 Pt 2):184S-189S. Review.

PMID:
15624338
36.

KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties.

Herrero AB, Magnelli P, Mansour MK, Levitz SM, Bussey H, Abeijon C.

Eukaryot Cell. 2004 Dec;3(6):1423-32.

37.

Blood, sweat, and tears: wasted by Medicare's missed opportunity.

Bussey HI.

Pharmacotherapy. 2004 Dec;24(12):1655-8. No abstract available.

PMID:
15585434
38.

Integrative studies put cell wall synthesis on the yeast functional map.

Firon A, Lesage G, Bussey H.

Curr Opin Microbiol. 2004 Dec;7(6):617-23. Review.

PMID:
15556034
39.

Combining biological networks to predict genetic interactions.

Wong SL, Zhang LV, Tong AH, Li Z, Goldberg DS, King OD, Lesage G, Vidal M, Andrews B, Bussey H, Boone C, Roth FP.

Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15682-7. Epub 2004 Oct 20.

40.

An in vitro assay for (1 --> 6)-beta-D-glucan synthesis in Saccharomyces cerevisiae.

Vink E, Rodriguez-Suarez RJ, Gérard-Vincent M, Ribas JC, de Nobel H, van den Ende H, Durán A, Klis FM, Bussey H.

Yeast. 2004 Oct 15;21(13):1121-31.

41.

Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, Pauker SG.

Chest. 2004 Sep;126(3 Suppl):457S-482S. Review.

PMID:
15383481
42.

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E.

Chest. 2004 Sep;126(3 Suppl):204S-233S. Erratum in: Chest. 2005 Jan;127(1):415-6. Dosage error in article text.

PMID:
15383473
43.

Heparin overview and issues.

Bussey H, Francis JL; Heparin Consensus Group.

Pharmacotherapy. 2004 Aug;24(8 Pt 2):103S-107S. Review.

PMID:
15334855
44.
45.
46.

Global mapping of the yeast genetic interaction network.

Tong AH, Lesage G, Bader GD, Ding H, Xu H, Xin X, Young J, Berriz GF, Brost RL, Chang M, Chen Y, Cheng X, Chua G, Friesen H, Goldberg DS, Haynes J, Humphries C, He G, Hussein S, Ke L, Krogan N, Li Z, Levinson JN, Lu H, Ménard P, Munyana C, Parsons AB, Ryan O, Tonikian R, Roberts T, Sdicu AM, Shapiro J, Sheikh B, Suter B, Wong SL, Zhang LV, Zhu H, Burd CG, Munro S, Sander C, Rine J, Greenblatt J, Peter M, Bretscher A, Bell G, Roth FP, Brown GW, Andrews B, Bussey H, Boone C.

Science. 2004 Feb 6;303(5659):808-13.

47.

Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery.

Roemer T, Jiang B, Davison J, Ketela T, Veillette K, Breton A, Tandia F, Linteau A, Sillaots S, Marta C, Martel N, Veronneau S, Lemieux S, Kauffman S, Becker J, Storms R, Boone C, Bussey H.

Mol Microbiol. 2003 Oct;50(1):167-81.

49.

Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.

Reese AM, Talbert RL, Bussey HI.

N Engl J Med. 2003 Jul 3;349(1):90-3; author reply 90-3. No abstract available.

PMID:
12846228
50.

A Saccharomyces cerevisiae genome-wide mutant screen for altered sensitivity to K1 killer toxin.

Pagé N, Gérard-Vincent M, Ménard P, Beaulieu M, Azuma M, Dijkgraaf GJ, Li H, Marcoux J, Nguyen T, Dowse T, Sdicu AM, Bussey H.

Genetics. 2003 Mar;163(3):875-94.

Supplemental Content

Loading ...
Support Center